Alexion Pharmaceuticals, Inc. Blog | Talkmarkets

Latest Posts

5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates

Article By: Zacks Investment Research

Wednesday, January 22, 2020 4:00 PM EST

A highlight of five big drug/biotech companies, which are expected to deliver positive earnings surprise in their upcoming quarterly earnings announcements.

In this article: AZN, MRK, ALXN, AMGN, ABBV

Read

Alexion To Acquire Achillion Pharma For $930M

Article By: Benzinga

Wednesday, October 16, 2019 9:06 AM EST

Alexion Pharma will buy Achillion Pharma for the initial value of $930 million, or $6.30 per share in cash plus added contingent considerations for a total potential value of $8.30 per share.

In this article: ALXN, ACHN

Read

3 Big Drug/Biotech Stocks Set To Beat Q3 Earnings Estimates

Article By: Zacks Investment Research

Saturday, October 12, 2019 10:00 AM EST

Overall, relatively newer drugs have been driving the top line of most of the big shots backed by higher demand - a trend we expect to have benefited third-quarter sales.

In this article: LLY, ALXN, AMGN Also: JNJ

Read

Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months

Article By: T.J. Hayes

Monday, September 9, 2019 7:36 PM EST

The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.

In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB

Read